Under Armour-C
UA
4.70
-0.02
-0.42%
Under Armour-C
US · UA
#2812 by market cap
Listed 1970
4.70
-0.02
-0.42%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-08 08:14
Pre-market
4.73
+0.64%
After-hours
4.69
-0.21%
- Market cap
- 2.02B
- P/E (TTM)i
- -4.09
- P/Bi
- 1.41
- EPSi
- -1.16
- Div yieldi
- 0.00%
- 52W posi
- 19%
Reader sentiment
Are you bullish or bearish on UA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.85, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.83% YoY
Margins
- Gross margin
- 45.48%
- Operating margin
- -0.71%
- Net margin
- -9.98%
Key ratios & quality
- Enterprise valuei
- 3.05B
- Altman Z-Scorei
- 1.85
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.27B | 4.47B | 5.68B | -- | 5.90B | 5.70B | 5.16B | 4.97B |
| Gross profit | 2.47B | 2.16B | 2.86B | -- | 2.64B | 2.63B | 2.47B | 2.26B |
| Selling & admin expenses | 2.23B | 2.17B | 2.33B | -- | 2.38B | 2.40B | 2.60B | 2.29B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 236.77M | -11.84M | 526.81M | -- | 263.59M | 229.75M | -127.25M | -35.39M |
| Pretax profit | 209.84M | -492.54M | 390.88M | -- | 267.86M | 262.07M | -204.76M | -200.68M |
| Tax | 70.02M | 49.39M | 32.07M | -- | -108.65M | 30.01M | -2.89M | 294.75M |
| Net profit | 92.14M | -549.18M | 360.06M | -- | 374.46M | 232.04M | -201.27M | -495.64M |
| Basic EPS | 0 | -1 | 1 | -- | 1 | 1 | 0 | -1 |
| Diluted EPS | 0.20 | -1.21 | 0.77 | -- | 0.81 | 0.52 | -0.47 | -1.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.13B | 1.33B | 1.33B | 1.17B | 1.10B |
| Gross profit | 550.78M | 546.50M | 630.58M | 589.74M | 492.04M | 593.83M |
| Selling & admin expenses | 607.13M | 530.35M | 581.63M | 664.54M | 517.73M | 543.09M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -56.35M | 16.15M | 48.95M | -74.80M | -25.70M | 50.75M |
| Pretax profit | -80.12M | -5.42M | 7.50M | -160.26M | -42.50M | 29.08M |
| Tax | -12.20M | -2.66M | 25.94M | 270.60M | 866.00K | 28.31M |
| Net profit | -67.46M | -2.61M | -18.81M | -430.83M | -43.39M | 545.00K |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 |
| Diluted EPS | -0.16 | -0.01 | -0.04 | -1.01 | -0.10 | 0.00 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.70B | 3.22B | 3.34B | 2.83B | 2.95B | 2.86B | 2.33B | 2.72B |
| Cash & ST investments | 788.07M | 1.52B | 1.67B | 1.01B | 710.93M | 858.69M | 501.36M | 309.17M |
| Inventory | 892.26M | 895.97M | 811.41M | 824.46M | 1.19B | 958.50M | 945.84M | 914.75M |
| Total assets | 4.84B | 5.03B | 4.99B | 4.45B | 4.83B | 4.76B | 4.30B | 4.42B |
| Total current liabilities | 1.42B | 1.41B | 1.45B | 1.30B | 1.36B | 1.17B | 1.11B | 1.68B |
| Short-term debt | 125.90M | 162.56M | 138.66M | 134.83M | 140.99M | 220.25M | 130.05M | 752.89M |
| Long-term debt | 592.69M | 1.00B | 662.53M | 672.29M | 674.48M | 594.87M | 595.13M | 590.61M |
| Total liabilities | 2,693,444,000.00 | 3,354,635,000.00 | 2,902,402,000.00 | 2,723,878,000.00 | 2,861,406,000.00 | 2,607,448,000.00 | 2,410,593,000.00 | 3,001,334,000.00 |
| Total equity | 2.15B | 1.68B | 2.09B | 1.73B | 1.97B | 2.15B | 1.89B | 1.41B |
| Retained earnings | 1.23B | 673.86M | 1.03B | 721.93M | 897.31M | 1.05B | 746.28M | 217.35M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.33B | 2.90B | 2.94B | 2.99B | 2.72B | 2.37B |
| Cash & ST investments | 501.36M | 910.99M | 395.99M | 464.65M | 309.17M | 395.98M |
| Inventory | 945.84M | 1.14B | 1.04B | 1.07B | 914.75M | 1.11B |
| Total assets | 4.30B | 4.87B | 4.90B | 4.63B | 4.42B | 4.10B |
| Total current liabilities | 1.11B | 1.90B | 1.74B | 2.09B | 1.68B | 1.31B |
| Short-term debt | 130.05M | 728.40M | 736.84M | 740.34M | 752.89M | 152.64M |
| Long-term debt | 595.13M | 389.46M | 589.78M | 390.05M | 590.61M | 591.16M |
| Total liabilities | 2,410,593,000.00 | 2,990,762,000.00 | 3,043,800,000.00 | 3,194,924,000.00 | 3,001,334,000.00 | 2,669,971,000.00 |
| Total equity | 1.89B | 1.87B | 1.86B | 1.44B | 1.41B | 1.43B |
| Retained earnings | 746.28M | 736.18M | 692.12M | 260.99M | 217.35M | 210.41M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 509.03M | 212.86M | 664.83M | -- | -39.89M | 353.97M | -59.32M | -75.09M |
| Depreciation & amortization | 186.43M | 164.98M | 141.14M | -- | 135.46M | 142.59M | 135.80M | 109.62M |
| Free cash flow | 363.23M | 120.57M | 595.07M | -- | -197.95M | 203.64M | -228.00M | -162.16M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | -- | -125.00M | -75.00M | -90.00M | -25.00M |
| Ending cash balance | 796.01M | 1.53B | 1.68B | -- | 726.75M | 876.92M | 515.05M | 312.06M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -202.20M | 48.85M | -69.83M | 278.06M | -332.17M | 109.14M |
| Depreciation & amortization | 39.02M | 28.98M | 27.26M | 27.29M | 26.09M | 25.42M |
| Free cash flow | -231.02M | 13.49M | -90.32M | 261.94M | -347.27M | 94.54M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -25.00M | -- | -- | 0 | 0 | -- |
| Ending cash balance | 515.05M | 925.16M | 399.77M | 468.39M | 312.06M | 398.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.42 | -28.71 | 19.13 | -- | 20.75 | 11.18 | -9.95 | -30.00 |
| ROA %i | 2.03 | -11.12 | 7.19 | -- | 8.31 | 4.83 | -4.44 | -11.37 |
| ROIC %i | 3.43 | -14.44 | 9.90 | -- | 11.50 | 6.52 | -5.93 | -15.15 |
| 5-year avg ROE %i | 5.17 | -3.65 | -1.97 | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.39 | -9.95 | 9.27 | -- | 4.81 | 4.03 | -2.46 | -0.71 |
| FCF / sales %i | 6.90 | 2.69 | 10.47 | -- | -- | 3.57 | -- | -- |
| Current ratioi | 1.90 | 2.28 | 2.30 | 2.18 | 2.17 | 2.46 | 2.10 | 1.62 |
| Quick ratioi | 1.05 | 1.45 | 1.54 | 1.32 | 1.08 | 1.39 | 1.06 | 0.59 |
| Debt / assetsi | 26.82 | 39.87 | 30.14 | 33.15 | 31.51 | 30.31 | 30.21 | 43.93 |
| LT debt / equityi | 54.57 | 109.96 | 65.37 | 77.58 | 70.20 | 56.78 | 61.86 | 83.91 |
| Interest coveragei | 10.88 | -9.42 | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 2.91 | -3.56 | 3.05 | -- | 13.13 | 0.14 | -- | -5.60 |
| Net income CAGR (3Y) %i | -28.96 | -- | -- | -- | -- | -17.74 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | 9.13 | -- | -- | -37.92 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -9.95 | 5.50 | -4.56 | -30.39 | -30.00 | -29.82 |
| ROA %i | -4.44 | 2.09 | -1.87 | -11.22 | -11.37 | -10.99 |
| ROIC %i | -5.93 | 3.03 | -2.48 | -16.21 | -15.15 | -15.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.46 | 3.20 | 0.72 | -1.33 | -0.71 | -0.02 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.10 | 1.53 | 1.69 | 1.43 | 1.62 | 1.81 |
| Quick ratioi | 1.06 | 0.81 | 0.62 | 0.52 | 0.59 | 0.80 |
| Debt / assetsi | 30.21 | 34.44 | 38.78 | 36.47 | 43.93 | 33.58 |
| LT debt / equityi | 61.86 | 50.54 | 62.67 | 66.07 | 83.91 | 85.67 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Apparel is the largest reported line at 66.86% of revenue, across 5 reported segments.
- Footwear follows at 22.34%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Apparel66.86%
Footwear22.34%
Accessories8.72%
License revenues2.26%
Quote time 2026-10-08 08:14:07 · For reference only, not investment advice and not tailored to your situation.